02877 SHINEWAY PHARM
WatchlistSHINEWAY PHARM News
SHINEWAY PHARM: 2023 Interim Report
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
SHINEWAY PHARM: 2023 INTERIM RESULTS ANNOUNCEMENT
SHINEWAY PHARM: Second interim dividend in respect of the fiscal year 2023
SHINEWAY PHARM: Notice of Board Meeting
SHINEWAY PHARM: POSITIVE PROFIT ALERT
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
SHINEWAY PHARM: AMENDED AND RESTATED ARTICLES OF ASSOCIATION
SHINEWAY PHARM: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 MAY 2023
SHINEWAY PHARM: TURNOVER FOR THE FIRST QUARTER OF 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
SHINEWAY PHARM: NOTICE OF ANNUAL GENERAL MEETING
SHINEWAY PHARM: Notification Letter to Non-Registered Shareholders (Notice of Publication of Environmental, Social and Governance Report 2022 of the Company)
SHINEWAY PHARM: Notification Letter to Shareholders (Notice of Publication of Environmental, Social and Governance Report 2022 )
SHINEWAY PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
SHINEWAY PHARM: Form of proxy for use at the annual general meeting to be held on Tuesday, 30 May 2023 (or at any adjournment thereof)
SHINEWAY PHARM: PROPOSALS FOR GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF RETIRING DIRECTORS, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION AND NOTICE O
SHINEWAY PHARM: Annual report 2022